BILLS-116hr5031ih.pdf

01:55 Nov 20, 2019 5031 2019 a fiscal year fiscal year such fiscal year at least 60 days the fiscal year each fiscal year the first fiscal year a calendar year the prior fiscal year 23 year previous calendar year 38 later than 180 calendar days 1ST SESSION H. R. 5031 15 years NOVEMBER 8, 2019 7 year calendar year the next fiscal year 60 days 5-year annual 30 days first fiscal year October 1 of each fiscal year the calendar year 1986 that year the end of a fiscal year 7 2019 each subsequent fiscal year

the ‘‘Medical Innovation Act

PO 00000 PO 00000 Frm 00005 PO 00000 Frm 00006 PO 00000 Frm 00007 PO 00000 Frm PO 00000 Frm 00013 PO 00000 Frm 00017 PO 00000 Frm 00019 PO 00000 Frm 00009 PO 00000 Frm 00003 Fmt PO 00000 Frm 00015 PO 00000 Frm 00001 PO 00000 Frm 00018 PO 00000 Frm 00004 PO 00000 Frm 00008 Fmt PO 00000 Frm 00020 PO 00000 Frm 00002 PO 00000 Frm 00016 PO 00000 Frm 00010 PO 00000 Frm 00021 Fmt PO 00000 Frm 00011 Fmt PO 00000 Frm 00022

United States the United States of America United

Cosmetic

the Federal Food, Drug the Federal Government Federal Senate the National Institutes of Health Federal Government FDA the Food and Drug Administra- MENTS Food, Drug TRICARE CONGRESSIONAL United 21 States the State Children’s Health U.S.C. Energy and Commerce CONGRESS National SEC Drug Administration the Internal Revenue Code Medicare the Committee on Energy and Commerce MENTS.—A House of Representa- Labor Committee the Food and Drug Administration THE HOUSE OF REPRESENTATIVES Institutes of Health the Medical Innovation Act the Committee on Health VESTMENTS 16 Exchange Commission Drug Administration Safety and Innovation Act the United States Government House of Representatives 14 cal year

WELCH

medical research alleged drug relates investments settlement manufacturer covered person described patent federal government medical research violation claims